beroe-ai

In-vitro Toxicology
Market, Supplier, Risk and
Competitive Intelligence

best-value

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai™

feature

 No Additional Benefits

Not ready yet? Schedule your free Demo

Subscription Benefits:

  • PRO access to Beroe LiVE.Ai™
  • Category Report with unlimited updates
  • Supplier Watchlist for 3 suppliers
  • Supplier Shortlisting Tool

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai™

feature

Manage In-vitro Toxicology Category with Ai powered
Procurement Productivity Suite

meet-abi-1

Abi will answer all In-vitro Toxicology related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on In-vitro Toxicology to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

meet-abi-1

Abi will answer all In-vitro Toxicology related
procurement queries with relevant data points

Abi - AI powered digital procurement assistant

discover-market-info

Get up-to-date market and supplier info on In-vitro Toxicology to help you build

Intelligence covers market and price outlook, SWOT analysis, demand & supply drivers, engagement models and Procurement best practices

1

Intelligence on category covers the following aspects market outlook, supply market, SWOT analysis, Cost components & Price outlook, Demand and supply drivers, Engagement Models and Procurement Best Practices

manage-risk

Assess Supplier Risk based on key risk and compliance parameters

1

Supplier assessment covers the following parameters Financial Risk, Ethical, Labor, Environmental Compliance, IT Security.

2

Supplier assessment is powered by world’s leading data partners including D&B, CreditSafe, Dow Jones, Refinitiv, Orpheus

discover-supplier

Identify right fit suppliers based on your selection criteria including revenue, capabilities, certification, geography

1

Select suppliers based on industry, country, classification from a database of 4.2 mn suppliers. Get detailed supplier profiles with supplier capabilities, revenue, certifications, risk ratings

assess-category-perforamnce

Benchmark your category performance against peers and the market

1

Measure category performance on 15 key parameters across cost, risk and strategy KPIs

source-market-indices

Get information on key factors affecting your supply

1

Source Macro Data and Market Indices information from leading data sources across these key areas - Labor Rates, Currency, Energy, Country Risk, Trade Flow/Transportation, Port Data, Tariff, Weather and Epidemics

Get Beroe LiVE.Ai™ subscription for your team

17k + companies trust Beroe for their supply market intelligence needs

Check out what’s included in market information for In-vitro Toxicology on Beroe LiVE.Ai™

Learn More about Beroe LiVE.Ai™

Report Coverage

  • Global Capacity–Demand Analysis
  • Global Trade Dynamics
  • Regional Market Snapshot-North America, Europe, Asia
  • Cost Structure Analysis

Market Size

Global Market Size

$8.47 Billion

CAGR

9-10 Percent

Table of contents

  1. In-vitro Toxicology Executive Summary
  2. Executive Summary: In-vitro Toxicology
  3. COVID –19 Impact Update
  1. In-vitro Toxicology Market Analysis
  2. In-vitro Toxicology Testing Market
  3. Growth Drivers and Constraints
  4. Porter's Five Forces Analysis
  5. MarketTrends
  6. Regional Overview –Australia
  1. Cost Drivers and Cost Structure
  2. Cost Drivers and Cost Structure

 

  1. Market Monitoring Insights
  2. Billing Rates Overview
  3. In-Vitro Toxicology Testing –Billing Rates
  4. Billing Rates: Benchmarking

 

  1. Sourcing Practices
  2. Sourcing Practices

 

  1. Supplier Section
  2. Key Global Suppliers
  3. Key Global Supplier Profile
  4. Key Global Supplier: SWOT

Want a more detailed personalised report?

In-vitro Toxicology Testing Market

  • Emergence of new approaches of 3D cell culture can boost the in vitro toxicity testing market. 3D cell culture represents thenext generation of in vitro toxicology testing market.
  • Increase in adoption of outsourcing due to increase in research expenditure. Rising technological advancements and growing opposition to the animal testing have paved way for the growing demand for in-vitro toxicology market.
  • The focus is on emergence of novel technology mostly with CROs to support with the global in-vitro toxicology requirements
  • Given the high emphasis on quality, sponsors heavily depend on dominant supply locations like North America and Europe for skilled FTE and testing infrastructure

  • In-vitro Toxicology Tests at Pharma Companies
  • Around 99 percent of usage is seen in the three main areas, namely ADME, safety pharmacology, and genotoxicity
  • Overall, a large and steady increase in the use of in-vitro tests was observed for both pharmaceutical companies and CROs since 2000
  • There was a large difference in the total number of compounds between pharmaceutical companies and CROs, with pharmaceutical companies peaking at over 180,000 and CROs peaking at over 500 tests per annum

Growth Drivers and Constraints

Drivers

  • Opposition to animal testing in drug development
  • Increasing R&D to detect toxicity at early stages. Investigative toxicology group that de-risks findings observed in non-clinical studies
  • Novel and promising technologies in analytical laboratories
  • Rapid up gradation of databases that serve information for toxicity profiling and lethal dose determination of different compounds
  • Multiple regulatory endpoint verifications
  • Increase in demand for in-vitro models as compared to in-vivo models
  • Increased global illicit drug abusers
  • Enhanced efficiency of IVTT in cancer diagnosis

Constraints

  • Predictive ability of the tests, stringent regulatory framework, and the inability of in-vitro models to detect certain anomalies are the major challenges faced by the market
  • Inability of in-vitro models to detect autoimmunity and immunostimulation
  • Despite the growing popularity of outsourcing, in-house ADME-Toxicology testing still accounts for four-fifth of the industry's total expenditure
  • There are also some in-vivo tests, for which, no in-vitro alternatives have yet been developed that exhibit acceptable predictability, such as for complex toxicological endpoints

Pricing Models

  • The pricing model adoption rate for in-vitro services varies with the geographies, due to the variation in engagement terms, as well as the type and duration of the project outsourced
  • The pricing model adoption rate for discovery research biology services remains similar across the geographies, as the outsourcing of services in this category is still in nascent stages
  • Presently, FFS is the preferred model, but with increased outsourcing penetration and greater volume of work, it would shift to FTE, as it offers more flexibility, visibility of spend, and cost savings

 

With this purchase you will be subscribed for a 12-month PRO membership to AI Powered Procurement Productivity Suite - Beroe LiVE.Ai™

feature

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.

x

Join us on Oct 6 for a webinar on Managing Inflation and Supply Shortages